EQ‐5D‐5L
Maintenance in the VAS score at weeks 12 and 18 were observed for the both the tislelizumab and docetaxel arms (Table Change from Baseline for EQ‐5D‐5L VAS Scores at Week 12 and Week 18.Abbreviations: EQ‐5D‐5L, EuroQoL Five‐Dimensions Five‐Levels; SD, standard deviation; VAS, visual analogue scale.